Agkistrodon haemocoagulase - KONRUNS PharmaceuticalAlternative Names: SuLing
Latest Information Update: 21 Oct 2016
At a glance
- Originator KONRUNS Pharmaceutical
- Class Coagulants; Crotalid venoms
- Mechanism of Action Fibrinogen stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Haemorrhage